This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Amf Gmbh, Baylor College of Medicine. Active years: 1985-1988.
Company Filing History:
Years Active: 1985-1988
Title: The Innovations of Gordon R. Dreesman
Introduction
Gordon R. Dreesman is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of immunology through his innovative patents. With a total of 2 patents, Dreesman has focused on developing methods and compositions that enhance immunological responses.
Latest Patents
Dreesman's latest patents include a cyclic peptide and method of use for inducing an immunological response. This composition is designed to elicit the production of antibodies to the hepatitis B surface antigen and neutralize the infectivity of the hepatitis B virus. The cyclic polypeptide he developed features a disulfide bond in a hydrophilic region, specifically in residues 117-137 or 122-137, with an amino acid sequence distinct from the native 25,000 molecular weight polypeptide derived from hepatitis B surface antigen. Another significant patent involves an immunoassay employing monoclonal herpes simplex antibody. This immunoassay and kit are intended for determining a viral antigen, such as herpes simplex, by immunocapturing the antigen with an insoluble matrix presenting IgG antibody against the viral antigen.
Career Highlights
Throughout his career, Dreesman has worked with reputable organizations, including Amf GmbH and Baylor College of Medicine. His work in these institutions has allowed him to collaborate with other professionals in the field, further enhancing his contributions to medical science.
Collaborations
Dreesman has collaborated with notable coworkers such as James T. Sparrow and Cynthia E. Kendall. These partnerships have played a crucial role in advancing his research and patent developments.
Conclusion
Gordon R. Dreesman is a distinguished inventor whose work in immunology has led to significant advancements in the field. His innovative patents reflect his commitment to improving health outcomes through scientific research and collaboration.